Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Monoclonal Mouse Antibody Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

new_biaoQian Monoclonal Mouse Antibody

According to our (Global Info Research) latest study, the global Monoclonal Mouse Antibody market size was valued at USD 9246.8 million in 2023 and is forecast to a readjusted size of USD 12260 million by 2030 with a CAGR of 4.1% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Monoclonal Mouse Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

new_biaoQian Monoclonal Mouse Antibody

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

USD3480.00

Add To Cart

Add To Cart

industry 02 Jan 2024

industry Medical Care

new_biaoQian Monoclonal Mouse Antibody

According to our (Global Info Research) latest study, the global Monoclonal Mouse Antibody market size was valued at USD 9246.8 million in 2023 and is forecast to a readjusted size of USD 12260 million by 2030 with a CAGR of 4.1% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Medical Care

new_biaoQian Monoclonal Mouse Antibody

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

USD3480.00

addToCart

Add To Cart